171Indexed trials
mesh condition
Seizures
Intelligence
Seizures intelligence: 171 indexed trials, 33 recruiting studies, 119 sponsors across 65 countries.
33Recruiting
119Sponsors
65Countries
Leading sponsors
GlaxoSmithKline70 recruiting
Eisai Inc.61 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)60 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.50 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.50 recruiting
Jazz Pharmaceuticals41 recruiting
Eisai Co., Ltd.31 recruiting
SK Life Science, Inc.30 recruiting
Johns Hopkins University30 recruiting
Dartmouth-Hitchcock Medical Center31 recruiting
UCB Pharma30 recruiting
Beth Israel Deaconess Medical Center21 recruiting
Geographic activity
United States94trials
Spain24trials
France23trials
United Kingdom20trials
Germany20trials
Italy16trials
Poland15trials
Hungary13trials
Australia13trials
Canada12trials
Belgium11trials
Mexico11trials
Leading interventions
Levetiracetam7trials
Lacosamide4trials
Perampanel4trials
topiramate4trials
levetiracetam3trials
Lamotrigine3trials
lacosamide2trials
Topiramate2trials
Vagus Nerve Stimulation Therapy2trials
Oxcarbazepine2trials
SPN-8172trials
Survey2trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.